Paediatric Drug Development

Paediatric drug development has become an essential part of drug development in recent years.

Health & Fitness, Pharmaceuticals/Drug Discovery

Paediatric Drug Development 3 Dec 2014 Holiday Inn Bloomsbury, London, United Kingdom
Submit new post
Thank you for posting.
Share it:

This masterclass, on paediatric drug development, will be lead by Dr. Klaus Rose. He is CEO of klausrose Consulting, Switzerland, advising on pediatric drug development and how to comply with FDA and EMA pediatric requirements. Mostly his clients are pharmaceutical companies and academic insitutions. He first studied Latin languages and psychology and then medicine. After postgraduate clinical training in General Medicine in Germany and England he joined pharmaceutical industry in 1991. He held various positions in R&D and medical affairs, was Global Head Pediatrics Novartis 2001 - 2005 and Global Head Pediatrics Roche 2005 - 2009. After a year with a regulatory consultancy he established his own business.

Dr. Rose is a frequent speaker on international conferences on pediatric drug development and publishes on a regular base. A textbook on pediatric formulations, co-edited with Prof. Bar-Shalom, University of Kopenhagen, DK, was released February 2014.

Price: Masterclass Fee: £599

From: December 03, 2014 08:30
To: December 03, 2014 15:30

Holiday Inn Bloomsbury, Coram Street, WC1N 1HT, London, United Kingdom


Health & Fitness, Pharmaceuticals/Drug Discovery


drug development, drugs discovery, paediatric, pharmaceutical

Contact email

Contact phone
+44 2078276134


Submitted by:

evvnt Platform

Are you the organizer?

Get in touch